Literature DB >> 3664505

Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro.

L H Augenlicht1, M Z Wahrman, H Halsey, L Anderson, J Taylor, M Lipkin.   

Abstract

A computer-based scanning and image-processing system has been developed to quantitate the relative level of expression of each of 4000 cloned complementary DNA sequences in small biopsies routinely removed from the mucosa of normal and neoplastic human large intestine. Individuals have been studied from well-defined population groups in which colonic epithelial cells have progressed to increasingly advanced stages of neoplastic transformation. Comparison of normal colonic mucosa to colonic carcinomas demonstrated alterations in expression of approximately 7% of the cloned sequences; fewer changes were found between benign colonic adenomas and either normal colonic mucosa or carcinomas. A subset of the sequences which change in expression during progression from normal mucosa, to adenoma, to carcinoma showed complementary changes when colon carcinoma cells were induced to differentiate in vitro with sodium butyrate; quantitative correlations between in vivo and in vitro results were highly significant. Comparison of normal colonic mucosa with mucosa from patients with the autosomal dominant disease familial polyposis revealed more extensive alterations in gene expression involving approximately 25% of the clones screened. Flat colonic mucosa in familial polyposis is therefore markedly aberrant and may be highly dedifferentiated, suggesting several possible mechanisms for the very high incidence of cancer that develops in this epithelium.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664505

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Hybridization fingerprinting of high-density cDNA-library arrays with cDNA pools derived from whole tissues.

Authors:  T M Gress; J D Hoheisel; G G Lennon; G Zehetner; H Lehrach
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Molecular genetics of colorectal carcinoma.

Authors:  I B Kerr
Journal:  BMJ       Date:  1989-09-09

3.  Cellular epigenetics: effects of passage history on competence of cells for "spontaneous" transformation.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

4.  Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein.

Authors:  K Pogue-Geile; J R Geiser; M Shu; C Miller; I G Wool; A I Meisler; J M Pipas
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma.

Authors:  S Markowitz; M Haut; T Stellato; C Gerbic; K Molkentin
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer.

Authors:  L H Augenlicht; J Taylor; L Anderson; M Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

7.  Genetic instability of cancer cells is proportional to their degree of aneuploidy.

Authors:  P Duesberg; C Rausch; D Rasnick; R Hehlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

8.  Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy.

Authors:  R Li; A Sonik; R Stindl; D Rasnick; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 9.  Virogenomics: the virus-host interaction revisited.

Authors:  Arno C Andeweg; Bart L Haagmans; Albert Dme Osterhaus
Journal:  Curr Opin Microbiol       Date:  2008-10-14       Impact factor: 7.934

Review 10.  Gene expression profiling: from microarrays to medicine.

Authors:  Ashani T Weeraratna; James E Nagel; Valeria de Mello-Coelho; Dennis D Taub
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.